Skip to main content
Equibles

Chas Schultz

Lexicon Pharmaceuticals, Inc. (LXRX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Lexicon Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get LXRX alerts

About Chas Schultz

Chas Schultz has spoken on 4 earnings calls across 1 company, most recently for Lexicon Pharmaceuticals, Inc. on February 28, 2022. Lexicon Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lexicon Pharmaceuticals, Inc. includes Michael Exton, Ph.D. (CEO and Board Member), Michael S. Exton (CEO and Board Member), Raymond Debbane (Chairman) and 7 others.

Chas Schultz on recent calls

“Good morning, and welcome to the Lexicon Pharmaceuticals’ fourth quarter 2021 financial results conference call.”
Chairman, Lexicon Pharmaceuticals, Inc. Q4 FY2021 Earnings Call ·
“Good afternoon, and welcome to the Lexicon Pharmaceuticals third quarter 2021 financial results conference call.”
Head of Investor Relations, Lexicon Pharmaceuticals, Inc. Q3 FY2021 Earnings Call ·
“Good afternoon and welcome to the Lexicon Pharmaceuticals first quarter 2021 financial results conference call. Joining me today are Lonnel Coats, Lexicon President and Chief Executive Officer and Jeff Wade, Lexicon's Executive Vice President of Corporate and Administrative Affairs and Chief Financial Officer.”
Head of Investor Relations, Lexicon Pharmaceuticals, Inc. Q1 FY2021 Earnings Call ·
“Good morning and welcome to the Lexicon Pharmaceuticals fourth quarter 2020 financial conference call.”
Head of Investor Relations, Lexicon Pharmaceuticals, Inc. Q4 FY2020 Earnings Call ·

Affiliation history

Company network

Leadership on record at Lexicon Pharmaceuticals, Inc.

Recent activity